Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound were no longer in shortage after nearly two years. Pharmacies that sold unbranded ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...